119 related articles for article (PubMed ID: 34121703)
21. Adverse drug reactions causing hospital admissions in childhood: a prospective, observational, single-centre study.
Langerová P; Vrtal J; Urbánek K
Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):560-4. PubMed ID: 24810357
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
[TBL] [Abstract][Full Text] [Related]
23. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
[TBL] [Abstract][Full Text] [Related]
24. Pattern of Adverse Drug Reactions Associated with the Use of Anticancer Drugs in an Oncology-Based Hospital of Nepal.
Tamang R; Bharati L; Khatiwada AP; Ozaki A; Shrestha S
JMA J; 2022 Oct; 5(4):416-426. PubMed ID: 36407064
[TBL] [Abstract][Full Text] [Related]
25. Quality of life and wellbeing among breast cancer patients in Lahore, Pakistan.
Ayub F; Khan TM; Baig MR; Amin MU; Tahir H
Front Oncol; 2023; 13():1105411. PubMed ID: 37456255
[TBL] [Abstract][Full Text] [Related]
26. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital.
Remesh A; Balan A; Gnanadurai A
J Basic Clin Physiol Pharmacol; 2014 Feb; 25(1):125-30. PubMed ID: 24423467
[TBL] [Abstract][Full Text] [Related]
27. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
[TBL] [Abstract][Full Text] [Related]
28. Pattern of Adverse Drug Reactions Reported with Cardiovascular Drugs in a Tertiary Care Teaching Hospital.
Palaniappan M; Selvarajan S; George M; Subramaniyan G; Dkhar SA; Pillai AA; Jayaraman B; Chandrasekaran A
J Clin Diagn Res; 2015 Nov; 9(11):FC01-4. PubMed ID: 26675485
[TBL] [Abstract][Full Text] [Related]
29. Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital.
Wahlang JB; Laishram PD; Brahma DK; Sarkar C; Lahon J; Nongkynrih BS
Ther Adv Drug Saf; 2017 Feb; 8(2):61-66. PubMed ID: 28255433
[TBL] [Abstract][Full Text] [Related]
30. Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian survey.
Lorusso D; Bria E; Costantini A; Di Maio M; Rosti G; Mancuso A
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 28004440
[TBL] [Abstract][Full Text] [Related]
31. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
Grassi L; Berardi MA; Ruffilli F; Meggiolaro E; Andritsch E; Sirgo A; Caruso R; Juan Linares E; Bellé M; Massarenti S; Nanni MG;
Psychother Psychosom; 2015; 84(6):339-47. PubMed ID: 26402426
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
[TBL] [Abstract][Full Text] [Related]
33. The incidence of nausea in the absence of vomiting in patients receiving intravenous chemotherapy.
Smit T; Kotze I; du Plessis J
Ann Palliat Med; 2021 Mar; 10(3):2679-2686. PubMed ID: 33549001
[TBL] [Abstract][Full Text] [Related]
34. Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a university hospital in New Delhi.
Alam MS; Pillai KK; Abdi SAH; Kapur P; Pillai PK; Nagarajan K
Korean J Intern Med; 2018 Nov; 33(6):1203-1209. PubMed ID: 28874042
[TBL] [Abstract][Full Text] [Related]
35. Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study.
Surendiran A; Balamurugan N; Gunaseelan K; Akhtar S; Reddy KS; Adithan C
Indian J Pharmacol; 2010 Feb; 42(1):40-3. PubMed ID: 20606836
[TBL] [Abstract][Full Text] [Related]
36. Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer.
Perwitasari DA; Atthobari J; Mustofa M; Dwiprahasto I; Hakimi M; Gelderblom H; Putter H; Nortier JW; Guchelaar HJ; Kaptein AA
Int J Gynecol Cancer; 2012 Jan; 22(1):139-45. PubMed ID: 22080888
[TBL] [Abstract][Full Text] [Related]
37. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
[TBL] [Abstract][Full Text] [Related]
38. The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life.
Farrell C; Brearley SG; Pilling M; Molassiotis A
Support Care Cancer; 2013 Jan; 21(1):59-66. PubMed ID: 22610269
[TBL] [Abstract][Full Text] [Related]
39. Cohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome.
Inoue M; Shoji M; Shindo N; Otsuka K; Miura M; Shibata H
BMC Pharmacol Toxicol; 2015 Mar; 16():5. PubMed ID: 25889295
[TBL] [Abstract][Full Text] [Related]
40. A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre.
Molassiotis A; Saunders MP; Valle J; Wilson G; Lorigan P; Wardley A; Levine E; Cowan R; Loncaster J; Rittenberg C
Support Care Cancer; 2008 Feb; 16(2):201-8. PubMed ID: 17926070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
